Annual Accounts Receivable
$23.62 M
-$5.32 M-18.38%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual accounts receivable is $23.62 million, with the most recent change of -$5.32 million (-18.38%) on June 30, 2024.
- During the last 3 years, AYTU annual accounts receivable has fallen by -$4.56 million (-16.18%).
- AYTU annual accounts receivable is now -18.38% below its all-time high of $28.94 million, reached on June 30, 2023.
Performance
AYTU Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$23.16 M
-$458.00 K-1.94%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly accounts receivable is $23.16 million, with the most recent change of -$458.00 thousand (-1.94%) on September 30, 2024.
- Over the past year, AYTU quarterly accounts receivable has dropped by -$6.72 million (-22.50%).
- AYTU quarterly accounts receivable is now -31.97% below its all-time high of $34.04 million, reached on March 31, 2023.
Performance
AYTU Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AYTU Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.4% | -22.5% |
| 3 y3 years | -16.2% | +7.1% |
| 5 y5 years | +1256.7% | -18.0% |
AYTU Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | +8.8% | -32.0% | +6.7% |
| 5 y | 5-year | -18.4% | +1256.7% | -32.0% | +345.6% |
| alltime | all time | -18.4% | -100.0% | -32.0% | >+9999.0% |
Aytu BioPharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.16 M(-1.9%) |
| Jun 2024 | $23.62 M(-18.4%) | $23.62 M(-21.1%) |
| Mar 2024 | - | $29.93 M(+1.8%) |
| Dec 2023 | - | $29.40 M(-1.6%) |
| Sep 2023 | - | $29.88 M(+3.3%) |
| Jun 2023 | $28.94 M(+33.3%) | $28.94 M(-15.0%) |
| Mar 2023 | - | $34.04 M(+33.3%) |
| Dec 2022 | - | $25.55 M(-8.5%) |
| Sep 2022 | - | $27.92 M(+28.6%) |
| Jun 2022 | $21.71 M(-22.9%) | $21.71 M(-21.4%) |
| Mar 2022 | - | $27.61 M(+20.1%) |
| Dec 2021 | - | $22.99 M(+6.3%) |
| Sep 2021 | - | $21.63 M(-23.2%) |
| Jun 2021 | $28.18 M(+400.2%) | $28.18 M(-0.2%) |
| Mar 2021 | - | $28.23 M(+303.2%) |
| Dec 2020 | - | $7.00 M(+14.5%) |
| Sep 2020 | - | $6.11 M(+8.5%) |
| Jun 2020 | $5.63 M | $5.63 M(-44.8%) |
| Mar 2020 | - | $10.20 M(+96.3%) |
| Dec 2019 | - | $5.20 M(+204.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $1.71 M(-2.0%) |
| Jun 2019 | $1.74 M(+200.8%) | $1.74 M(+26.5%) |
| Mar 2019 | - | $1.38 M(-7.2%) |
| Dec 2018 | - | $1.48 M(+95.0%) |
| Sep 2018 | - | $760.10 K(+31.3%) |
| Jun 2018 | $578.80 K(+9.6%) | $578.80 K(-21.0%) |
| Mar 2018 | - | $732.50 K(-46.8%) |
| Dec 2017 | - | $1.38 M(+13.7%) |
| Sep 2017 | - | $1.21 M(+129.5%) |
| Jun 2017 | $528.00 K(+225.1%) | $528.00 K(+54.2%) |
| Mar 2017 | - | $342.50 K(-41.2%) |
| Dec 2016 | - | $582.40 K(+14.3%) |
| Sep 2016 | - | $509.40 K(+213.7%) |
| Jun 2016 | $162.40 K(+3.4%) | $162.40 K(+92.6%) |
| Mar 2016 | - | $84.30 K(-70.8%) |
| Dec 2015 | - | $288.50 K(+71.8%) |
| Sep 2015 | - | $167.90 K(+6.9%) |
| Jun 2015 | $157.10 K(>+9900.0%) | $157.10 K(>+9900.0%) |
| Mar 2015 | - | $1000.00 |
| Jun 2014 | $0.00 | - |
FAQ
- What is Aytu BioPharma annual accounts receivable?
- What is the all time high annual accounts receivable for Aytu BioPharma?
- What is Aytu BioPharma annual accounts receivable year-on-year change?
- What is Aytu BioPharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Aytu BioPharma?
- What is Aytu BioPharma quarterly accounts receivable year-on-year change?
What is Aytu BioPharma annual accounts receivable?
The current annual accounts receivable of AYTU is $23.62 M
What is the all time high annual accounts receivable for Aytu BioPharma?
Aytu BioPharma all-time high annual accounts receivable is $28.94 M
What is Aytu BioPharma annual accounts receivable year-on-year change?
Over the past year, AYTU annual accounts receivable has changed by -$5.32 M (-18.38%)
What is Aytu BioPharma quarterly accounts receivable?
The current quarterly accounts receivable of AYTU is $23.16 M
What is the all time high quarterly accounts receivable for Aytu BioPharma?
Aytu BioPharma all-time high quarterly accounts receivable is $34.04 M
What is Aytu BioPharma quarterly accounts receivable year-on-year change?
Over the past year, AYTU quarterly accounts receivable has changed by -$6.72 M (-22.50%)